Note: The information on cancer types on the ACRF website is not designed to provide medical or professional advice and is for information only. If you have any health problems or questions please consult your doctor.
Fallopian tube cancer is a cancer that arises from one or both of the fallopian tubes. The fallopian tubes are the tubular structures which connect the upper, outer-most part of the uterus with the ovary and provide a means for fertilisation of the female egg.
Cancer of the fallopian tube is rare. Primary fallopian tube cancer accounts for less than half of one percent of all cancers in Australian women.
Although fallopian tube cancer is rare, treatment is similar in many respects to treatment for ovarian cancer.
There are two types of fallopian tube cancer:
Fallopian tube cancer symptoms include:
If you are experiencing any of these symptoms, visit your doctor for a check-up. It is important to remember that most women with any of these symptoms will not have fallopian tube cancer.
There are generally two types of treatment used for cancer of the fallopian tubes: surgery and chemotherapy. Radiotherapy and hormonal therapy may sometimes be used.
The extent of the cancer will determine the type of surgery needed.
However, what is generally required is a hysterectomy (removal of the uterus), and removal of both fallopian tubes and both ovaries (a bilateral salpingo-oophorectomy).
The omentum (a protective apron of fatty tissue over the abdominal organs) is also usually removed, and multiple biopsies will be taken.
For advanced fallopian tube cancer (i.e. Stage 3), bowel resections may be required. This is an operation for the removal of a length of bowel (either the large bowel or the small bowel).
Chemotherapy will usually be given after surgery for fallopian tube cancer.
1 in 4
women will be diagnosed with cancer before the age of 75
of women aged 50–74 participated in breast screening programs
is the estimated 5-year survival rate for women with cancer
Together we can change the statistics and outsmart cancer for good
Cancer in Australia 2017, Australian Institute of Health and Welfare
Researchers will soon understand how to better target cancer treatments with the opening of a new Australian Cancer Research Foundation...
A recent UK study showed no significant difference in survival between men who had a single prostate-specific antigen (PSA) test – a bl...